Research on China Cardiovascular Drugs Industry, 2014-2018 primarily carries on analyses on cardiovascular drugs market in the following aspects: market scale, the scale of segment markets, current competition status and business performance of major drug manufacturers; meanwhile it makes predictions about prospective market so as to help investors know Cardiovascular Drugs Industry well and provide decision-making references for them. The report is in Chinese version now. The English version will be delivered in 3-5 business days Buy a Single User Report Price : US$2500 Purchase a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=288151 .

1. Research on China Cardiovascular Drugs
Industry, 2014-2018
Published: May 2014
No. of Pages: 54
Single User License: US$ 2500
Corporate User License: US$ 3750
Order this report by calling
+1 888 391 5441 or Send an email
to sales@reportsandreports.com
with your contact details and
questions if any.
© ReportsnReports.com / Contact sales@reportsandreports.com 1

2. Research on China Cardiovascular Drugs
Industry, 2014-2018
The report is in Chinese version now. The English version will be delivered in 3-5
business days.
Research on China Cardiovascular Drugs Industry, 2014-2018 primarily carries on
analyses on cardiovascular drugs market in the following aspects: market scale, the
scale of segment markets, current competition status and business performance of
major drug manufacturers; meanwhile it makes predictions about prospective
market so as to help investors know this industry well and provide decision-making
references for them.
With the aged tendency of population in China and the increasing morbidity of
chronic diseases which have to be treated with medicines for the rest of patients' life,
market scale of cardiovascular drugs is expanding. This trend has been reflected in
recent years. While in the next few years, with the reform of medical insurance in
China and the continuous standardization of pharmaceutical market as well as the
unique curative effect of Chinese patent medicines, Chinese patents medicines for
cardiovascular diseases will enjoy a promising development prospect.
Order this report by calling +1 888 391 5441 or Send an email to
sales@reportsandreports.com with your contact details and questions if any.
© ReportsnReports.com / Contact sales@reportsandreports.com 2

3. Research on China Cardiovascular Drugs
Industry, 2014-2018
In 2013 market scale of cardiovascular drugs has reached CNY 17.8 billion in China. At
present cardiovascular diseases have a relatively higher morbidity rate among all diseases
and also is a kind of disease that is hard to be cured. Along with the changes of people's
life-styles, the difficulties in curing cardiovascular diseases are becoming more prominent.
The compound annual growth rate of cardiovascular diseases is 21.6%, and the
prevalence rate of cardiovascular diseases will increase further because of the
improvements on people's living standards, the changes of life styles and increasing aging
population. The market will be expanded.
On the other hand, patients with cardiovascular diseases have stood at 290 million, and
patients with chronic diseases who have received systematic treatment account for a
small proportion. In the next ten years, there is a potential for the growth in
cardiovascular diseases treatment field. It is predicted that the growth rate will maintain
more than 20% from 2014 to 2018. Publisher estimates that the sales scale of
cardiovascular drugs in China in 2014 will reach about CNY 22 billion, and the figure will
be CNY 45 billion by 2018.
Complete report available @ http://www.reportsnreports.com/reports/288151-
research-on-china-cardiovascular-drugs-industry-2014-2018-.html .
.Order this report by calling +1 888 391 5441 or Send an email to
sales@reportsandreports.com with your contact details and questions if any.
© ReportsnReports.com / Contact sales@reportsandreports.com 3

4. Research on China Cardiovascular Drugs
Industry, 2014-2018
Table of Contents
1. Overview of China Cardiovascular Drugs Industry
2. Development Environment of China Cardiovascular Drugs Industry
3. Development Status of Pharmaceuticals Industry
4. Current Situation of Cardiovascular Drugs Market
5. Competitive Analysis of China Cardiovascular Chemical Drugs
6. Competitive Analysis of Chinese Patent Medicines for Cardiovascular System
7. Leading Enterprises of Cardiovascular Drugs Industry
7.2 Leading Enterprises of Cardiovascular Medicines in China
7.2.1 Beijing SL PHARM
7.2.2 SALUBRIS
7.2.3 TASLY Pharm.
7.2.4 Taiantang Group
7.2.5 Guizhou Yibai Pharmaceutical Co., Ltd.
Order this report by calling +1 888 391 5441 or Send an email to
sales@reportsandreports.com with your contact details and questions if any.
© ReportsnReports.com / Contact sales@reportsandreports.com 4

5. Research on China Cardiovascular Drugs
Industry, 2014-2018
ReportsnReports.com is your single source for all market research needs. Our database
includes 350,000+ syndicated market research reports from 100+ leading global
publishers covering in-depth analysis of over 5000 micro markets. With comprehensive
information about the publishers and their report methodology, data sources, etc. we
help you in your purchase decision by mapping your information needs with the most
relevant available reports in our library. Join us on social platforms to keep yourself
updated about the latest market intelligence for industry of your interest.
Get in touch with us at +1 888 391 5441 or Send an email to sales@reportsandreports.com
with your contact details and questions if any.
© ReportsnReports.com / Contact sales@reportsandreports.com 5